BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7913300)

  • 1. Amyloidosis in prion diseases and cells involved in PrP fibrillogenesis.
    Wisniewski HM; Wegiel J; Kozielski R
    Ann N Y Acad Sci; 1994 Jun; 724():191-209. PubMed ID: 7913300
    [No Abstract]   [Full Text] [Related]  

  • 2. Amyloid and prions: some biochemical investigations of cerebral amyloidosis in mice.
    Hope J; Kirby L
    Folia Neuropathol; 2012; 50(1):13-9. PubMed ID: 22505360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral amyloidosis in prion diseases.
    DeArmond SJ
    Amyloid; 2000 Mar; 7(1):3-6. PubMed ID: 10842694
    [No Abstract]   [Full Text] [Related]  

  • 4. Transmissible spongiform encephalopathies: virally transmitted amyloidoses.
    Diringer H; Oberdieck U; Malchow M; Beekes M
    Dev Biol Stand; 1993; 80():25-9. PubMed ID: 8270112
    [No Abstract]   [Full Text] [Related]  

  • 5. Alzheimer disease and the prion disorders amyloid beta-protein and prion protein amyloidoses.
    Price DL; Borchelt DR; Sisodia SS
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6381-4. PubMed ID: 8101988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human brain amyloidoses.
    Gambetti P; Russo C
    Nephrol Dial Transplant; 1998; 13 Suppl 7():33-40. PubMed ID: 9870435
    [No Abstract]   [Full Text] [Related]  

  • 7. Unifying features of systemic and cerebral amyloidosis.
    Ghiso J; Wisniewski T; Frangione B
    Mol Neurobiol; 1994 Feb; 8(1):49-64. PubMed ID: 7916192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Yeast prions, mammalian amyloidoses, and the problem of proteomic networks].
    Galkin AP; Mironova LN; Zhuravleva GA; Inge-Vechtomov SG
    Genetika; 2006 Nov; 42(11):1558-70. PubMed ID: 17163073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amyloidgenesis in prion disease].
    Tsuboi Y
    Brain Nerve; 2014 Jul; 66(7):849-55. PubMed ID: 24998829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurodegenerative amyloidoses: the yeast model].
    Vishnevskaia AB; Kushnirov VV; Ter-Avanesian MD
    Mol Biol (Mosk); 2007; 41(2):346-54. PubMed ID: 17514901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion-like aggregates: infectious agents in human disease.
    Westermark GT; Westermark P
    Trends Mol Med; 2010 Nov; 16(11):501-7. PubMed ID: 20870462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.
    Chesebro B; Race B; Meade-White K; Lacasse R; Race R; Klingeborn M; Striebel J; Dorward D; McGovern G; Jeffrey M
    PLoS Pathog; 2010 Mar; 6(3):e1000800. PubMed ID: 20221436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleation of amyloidogenesis in infectious and noninfectious amyloidoses of brain.
    Gajdusek DC
    Ann N Y Acad Sci; 1994 Jun; 724():173-90. PubMed ID: 8030940
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
    Kim DH; Lee HM; Ryou C
    J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of the real-time quaking-induced conversion assay in diagnosis, prion strain-typing, drug pre-screening and other amyloidopathies.
    Candelise N; Schmitz M; Da Silva Correia SM; Arora AS; Villar-Piqué A; Zafar S; Llorens F; Cramm M; Zerr I
    Expert Rev Mol Diagn; 2017 Oct; 17(10):897-904. PubMed ID: 28817974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metallothioneins in Prion- and Amyloid-Related Diseases.
    Adam P; Křížková S; Heger Z; Babula P; Pekařík V; Vaculovičoá M; Gomes CM; Kizek R; Adam V
    J Alzheimers Dis; 2016; 51(3):637-56. PubMed ID: 26923022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein folding pathology in domestic animals.
    Gruys E
    J Zhejiang Univ Sci; 2004 Oct; 5(10):1226-38. PubMed ID: 15362194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion and prion-like diseases in animals.
    Aguilar-Calvo P; García C; Espinosa JC; Andreoletti O; Torres JM
    Virus Res; 2015 Sep; 207():82-93. PubMed ID: 25444937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A kinetic model for amyloid formation in the prion diseases: importance of seeding.
    Come JH; Fraser PE; Lansbury PT
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5959-63. PubMed ID: 8327467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Yeast as a model for studying the prion and amyloid occurrence].
    Kryndushkin DS; Aleksandrov IM; Kushnirov VV; Ter-Avanesian MD
    Ross Fiziol Zh Im I M Sechenova; 2004 May; 90(5):645-57. PubMed ID: 15341089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.